Access

Utilization management should not undermine patient-centered care.  Nor should it override physician-patient decision making. Pricing should prioritize access. Manufacturers’ pricing process should include input from all stakeholders, including health care providers, patients and payers. Society shares both benefits and risks.  All stakeholders – including manufacturers, payers, patients and broader society – should enjoy the benefits, and help shoulder the cost burden, of advanced medicine.